Medtronic MiniMed 780G

Medtronic MiniMed 780 G insulin pump, Medtronic insulin delivery system

MiniMed™ 780G Insulin Pump system

Designed for real life.

Ever miss a meal dose sometimes or underestimate a carb count? Life with diabetes can be unpredictable. Now there’s an insulin pump system designed with Meal Detection technology* that automatically adjusts and corrects sugar levels every 5 minutes§.

For those times when you forget to plan ahead. Just like in real life.

Auto corrections

Worry less if your carb counts aren’t exact or if you occasionally miss a meal dose* – the system has you covered by delivering a correction dose.

No fingersticks with SmartGuard™ technology**

The new Guardian™ 4 sensor sends sugar levels to the pump every 5 minutes§ with no fingersticks required with SmartGuard™ technology.**

Personalized glucose targets

The only system with flexible glucose targets as low as 100 mg/dL.§

Self-adjusting technology

The system automatically adjusts insulin delivery all day and night to help prevent highs and lows.§

———- Discover More ———-

Ready to Get Started?

At EHCS, our goal is to provide you with a first-rate customer experience through the entire process. After you complete our online Medtronic form, EHCS will pair you with a dedicated Diabetes Care Advisor to help you through the process. From insurance approval and product selection to future reorders, our team of DCAs is your guide to better diabetes control.

Frequently Asked Questions

How do I order the MiniMed™ 780G system?

For new customers looking to order the MiniMed™ 780G system, enroll today to see if you qualify.


For customers using the MiniMed™ 770G insulin pump, you are eligible for a no-cost software upgrade.* Sign in to to see your options.

* Eligibility criteria and terms and conditions apply.

I’m on the MiniMed™ 770G pump, am I eligible for the upgrade?

Yes! You’ll be eligible for a no-cost software upgrade* even if you are out of warranty, until April 27, 2024. New prescription needed. Submit your order on

* Eligibility criteria and terms and conditions apply.

I’m already on a Medtronic insulin pump. Can I upgrade to the MiniMed™ 780G system?

All MiniMed™ 770G pump customers, regardless of warranty, will have access to a no-cost software upgrade* to the MiniMed™ 780G insulin pump until April 27, 2024. New prescription required.


For all other Medtronic pump customers, check your upgrade options on

* Eligibility criteria and terms and conditions apply.

What’s the difference between the MiniMed™ 780G system and the MiniMed™ 770G system?

The MiniMed™ 780G system is the only system with Meal Detection™  technology* that provides automatic adjustments and corrections to sugar levels every 5 minutes§. Meal Detection™ technology helps cover for underestimated carb counts or an occasionally missed meal bolus. Only the MiniMed™ 780G insulin pump pairs with the new Guardian™ 4 sensor, which requires no fingersticks** with SmartGuard™ technology. The new system also allows you and your healthcare provider to choose among 100, 110, and 120 mg/dL sugar targets to offer more flexibility in your diabetes management. For more details, see our comparison chart.


*Taking a bolus 15 – 20 minutes before a meal helps to keep blood sugar levels under control after eating.
 Refers to auto correct, which provides bolus assistance. Can deliver all auto correction doses automatically without user interaction, feature can be turned on and off.
§ Refers to SmartGuard™ feature. Individual results may vary
**Fingersticks required in manual mode & to enter SmartGuard™. If symptoms don’t match alerts & readings, use a fingerstick. Refer to user guide. Pivotal trial participants spend avg of > 93% in SmartGuard™.

Do I need a new prescription?

Yes, a new prescription is required for the MiniMed™ 780G software, as well as the Guardian™  4 sensors.

Who is this insulin pump recommended for?

The MiniMed™ 780G system is approved for people with Type 1 diabetes age 7 and over.

*Taking a bolus 15 – 20 minutes before a meal helps to keep blood sugar levels under control after eating.
 Refers to auto correct, which provides bolus assistance. Can deliver all auto correction doses automatically without user interaction, feature can be turned on and off.
 Actor Portrayal.
§ Refers to SmartGuard feature. Individual results may vary.
1 Matejko B. et al, Diabetes Care. 2022;
**Fingersticks required in manual mode and to enter SmartGuard. If symptoms don’t match alerts and readings, use a fingerstick. Refer to user guide. Pivotal trial participants spend avg of > 93% in SmartGuard.
2 Carlson, A.L. et al. (2022) “Safety and glycemic outcomes during the MiniMed™️ advanced hybrid closed-loop system pivotal trial in adolescents and adults with type 1 diabetes,” Diabetes Technology & Therapeutics, 24(3), pp. 178–189.
Φ Smart devices sold separately. For a list of compatible devices, visit

Important safety information: MiniMed 780G system with SmartGuard technology with Guardian 4 sensor

The MiniMed 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. The MiniMed 780G system includes SmartGuard technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values.

The Medtronic MiniMed 780G system consists of the following devices: MiniMed 780G insulin pump, the Guardian 4 transmitter, the Guardian 4 sensor, One-press serter, the Accu-Chek Guide Link blood glucose meter, and the Accu-Chek Guide test strips. The system requires a prescription from a healthcare professional.

The Guardian 4 sensor is intended for use with the MiniMed 780G system and the Guardian 4 transmitter to monitor glucose levels for the management of diabetes. The sensor is intended for single use and requires a prescription. The Guardian 4 sensor is indicated for up to seven days of continuous use.

The Guardian 4 sensor is not intended to be used directly to make therapy adjustments while the MiniMed 780G is operating in manual mode. All therapy adjustments in manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian 4 sensor. The Guardian 4 sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. Do not use the Guardian 4 sensor in the abdomen or other body sites including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia.

WARNING: Do not use the SmartGuard feature for people who require less than 8 units or more than 250 units of total daily insulin per day. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard feature.

WARNING: Do not use the MiniMed 780G system until appropriate training has been received from a healthcare professional. Training is essential to ensure the safe use of the MiniMed 780G system.

WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. When the SmartGuard feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. However, if your symptoms do not match the SG value, use a BG meter to confirm the SG value. Failure to confirm glucose levels when your symptoms do not match the SG value can result in the infusion of too much or too little insulin, which may cause hypoglycemia or hyperglycemia.

Pump therapy is not recommended for people whose vision or hearing does not allow for the recognition of pump signals, alerts, or alarms. The safety of the MiniMed 780G system has not been studied in pregnant women, persons with type 2 diabetes, or in persons using other anti-hyperglycemic therapies that do not include insulin. For complete details of the system, including product and important safety information such as indications, contraindications, warnings and precautions associated with system and its components, please consult and the appropriate user guide at

Your Cart